Glycogen Storage Diseases

  • Janis M. Ferns
  • Stephen H. HalpernEmail author


The inherited glycogen storage diseases (GSD) are rare inborn errors of glycogen metabolism. The diseases that survive to adulthood with implications for anesthesia are discussed here. They follow autosomal recessive inheritance. Strategies for medical management that are safe for both mother and fetus will be presented. The anesthetic management of labor and delivery as well as operative deliveries will be discussed.


Anesthesia Obstetrical McArdle disease Pompe disease Glycogen storage diseases 


  1. 1.
    Quinlivan R, Buckley J, James M, Twist A, Ball S, Duno M, et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry. 2010;81(11):1182–8.CrossRefGoogle Scholar
  2. 2.
    Godfrey R, Quinlivan R. Skeletal muscle disorders of glycogenolysis and glycolysis. Nat Rev Neurol. 2016;12(7):393–402.CrossRefGoogle Scholar
  3. 3.
    Karabul N, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, et al. Pregnancy and delivery in women with Pompe disease. Mol Genet Metab. 2014;112(2):148–53.CrossRefGoogle Scholar
  4. 4.
    Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, et al. Pregnancies in glycogen storage disease type 1a. Am J Obstet Gynecol. 2008;198(6):646.e1–7.CrossRefGoogle Scholar
  5. 5.
    Bolton SD, Clark VA, Norman JE. Multidisciplinary management of an obstetric patient with glycogen storage disease type 3. Int J Obstet Anesth. 2012;21(1):86–9.CrossRefGoogle Scholar
  6. 6.
    Cilliers HJ, Yeo ST, Salmon NP. Anaesthetic management of an obstetric patient with Pompe disease. Int J Obstet Anesth. 2008;17(2):170–3.CrossRefGoogle Scholar
  7. 7.
    Bali DS, Chen YT, Goldstein JL. Glycogen storage disease type I. 19 Apr 2006 [Updated 19 Sep 2013]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2016.
  8. 8.
    Rohman PJ, Scott E, Richfield L, Ramaswami U, Hughes DA. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease). J Obstet Gynaecol Res. 2016;42(10):1263–71. Scholar
  9. 9.
    Ramachandran R, Wedatilake Y, Coats C, Walker F, Elliot P, Lee PJ, et al. Pregnancy and its management in women with GSD type III—a single centre experience. J Inherit Metab Dis. 2012;35:245–51.CrossRefGoogle Scholar
  10. 10.
    Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L, et al. Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries. J Inherit Metab Dis. 2010;33(Suppl 3):S151–7.CrossRefGoogle Scholar
  11. 11.
    de Vries JM, Brugma JD, Ozkan L, Steegers EA, Reuser AJ, van Doorn PA, et al. First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease. Mol Genet Metab. 2011;104(4):552–5.CrossRefGoogle Scholar
  12. 12.
    Zagnoli F, Leblanc A, Blachard C. Pregnancy during enzyme replacement therapy for late-onset maltase deficiency. Neuromuscul Disord. 2013;23(2):180–1.CrossRefGoogle Scholar
  13. 13.
    Choleva AJ. Anesthesia considerations in a patient with McArdle disease: a case report. AANA J. 2011;79(3):243–7.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiaSunnybrook Health Sciences Centre, University of TorontoTorontoCanada

Personalised recommendations